TickerKhojComparison · NSE · data 2026-11-02
Kwality Pharmaceuticals Ltd vs Solara Active Pharma Sciences Ltd.
In plain words
Size: Kwality Pharmaceuticals Ltd is about 1.2 times the market value of Solara Active Pharma Sciences Ltd..
Valuation (P/E): Solara Active Pharma Sciences Ltd. 83.8 vs Kwality Pharmaceuticals Ltd 45.
Return on equity: Kwality Pharmaceuticals Ltd 22.6% vs Solara Active Pharma Sciences Ltd. -0.6%.
Debt to equity: Solara Active Pharma Sciences Ltd. 0.55 vs Kwality Pharmaceuticals Ltd 0.39.
Differences in the numbers, not a recommendation of either stock.
Side by side
| KPL | SOLARA | |
|---|---|---|
| Price | ₹3,511.3 | ₹629.7 |
| Market cap | ₹3,604 cr | ₹3,043 cr |
| P/E | 45 | 83.8 |
| P/B | — | 2.1 |
| ROE | 22.6% | -0.6% |
| ROCE | 31.4% | 5.9% |
| Debt / equity | 0.39 | 0.55 |
| Operating margin | 20.8% | 8.4% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 26.1% | -1.6% |
| Profit growth, 3 years (yearly) | 51.5% | — |
| 1-year return | 101.0% | 4.4% |
| Revenue, last 12 months | ₹554 cr | ₹1,535 cr |
| Net profit, last 12 months | ₹81 cr | ₹37 cr |
| Latest quarter | — | Sept 2026 |
| Quarter net profit | — | ₹28 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | 41.93% |
| Health check | Strong (8.4/10) | Weak (2.5/10) |
Common questions
Which has a higher P/E, Kwality Pharmaceuticals Ltd or Solara Active Pharma Sciences Ltd.?
Solara Active Pharma Sciences Ltd. trades at the higher P/E (83.8 against 45). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Kwality Pharmaceuticals Ltd (22.6% against -0.6%).
Which carries more debt?
Solara Active Pharma Sciences Ltd. has the higher debt-to-equity ratio (0.55 against 0.39).